Kurome Therapeutics

About:

Kurome Therapeutics is a preclinical stage company focused on subverting cancer's ability to evade therapy.

Website: https://kurometherapeutics.com

Top Investors: CincyTech, Medicxi, Affinity Asset Advisors, Queen City Angels

Description:

Kurome Therapeutics is a preclinical stage company focused on subverting cancer's ability to evade therapy. The company is developing therapies that target cancer cells that have co-opted immune signaling pathways to avoid destruction by traditional therapeutic agents and subvert adaptive resistance mechanisms.

Total Funding Amount:

$15M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cincinnati, Ohio, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)kurometx.com

Founders:

Daniel Starczynowski

Number of Employees:

11-50

Last Funding Date:

2021-06-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai